Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Silver jumps, stocks slide as social trading roils market

Fri, 29th Jan 2021 21:32

(Adds close of U.S. markets)

* Silver prices rise on social media speculation

* J&J falls as vaccine disappoints

* Bitcoin jumps 14% after Elon Musk mention

* Treasury yields rise after inflation data

By Herbert Lash and Carolyn Cohn

NEW YORK/LONDON, Jan 29 (Reuters) - Silver prices jumped and
global equity markets sank on Friday amid a growing battle on
Wall Street between hedge funds and retail investors, while a
dispute over COVID-19 vaccine supply in Europe cooled risk
appetite.

Disappointing vaccine data from Johnson & Johnson
also hurt sentiment but the assault of retail traders using
online forums to force hedge funds to reverse short positions -
bets that stocks will fall - kept the market on edge.

Shares of GameStop Corp and AMC Entertainment
Holdings Inc surged again after Robinhood and
Interactive Brokers said they planned to ease restrictions after
imposing buying halts on Thursday.

GameStop soared 67.9% to $325 a share, five times its
closing price a week ago Friday, and AMC gained 53.7%, both in
heavy trade. AMC was one of the most active stocks on the New
York Stock Exchange. Volume on U.S. exchanges was 16.83 billion
shares, up from the 10.6 billion average in the fourth quarter.

Silver rallied and was up 2% at $26.90 an ounce,
taking gains to almost 10% since messages began to circulate on
Reddit early Thursday urging retail investors to pile into the
market and drive up prices.

Anxiety has grown as investors ask whether hedge funds will
need to liquidate other positions to address losses in stocks
they have shorted, said Michael Arone, chief investment
strategist at State Street Global Advisors in Boston.

"Once this short squeeze inevitably ends and there aren't
any more greater fools to bid up these stocks, will retail
investors get stuck holding the bag?" Arone asked.

"The unintended consequences of this potential volatility
have markets on edge as we end the week," Arone said.

Arone added that investors need to take a giant step back as
earnings are strong, the economy is improving, fiscal and
monetary policy is supportive and vaccines are rolling out.

MSCI's benchmark for global equity markets
fell 1.82% to 642.57, while Europe's broad FTSEurofirst 300
index closed down 1.95% at 1,524.1 to post its worst
weekly loss, at 3.3%, since October.

On Wall Street, the Dow Jones Industrial Average fell
2.03%, the S&P 500 lost 1.93% and the Nasdaq Composite
dropped 2%. The three indexes suffered their biggest
weekly fall since the end of October.

MSCI's broadest index of Asia-Pacific shares outside Japan
fell 1.1% to post a weekly loss of 4.4%. Japan's
Nikkei fell 1.9%, recording its first weekly loss of the
year.

VACCINE DISPUTE

Delays in COVID-19 vaccine production have snowballed into a
spat between Britain, the European Union and drugmakers over how
best to direct limited supplies.

AstraZeneca Plc offered eight million more doses of
its COVID-19 vaccine to the European Union after it unexpectedly
announced supply cuts last week. But the bloc said that was far
short of what was originally promised, an EU official told
Reuters on Friday.

New variants of the novel coronavirus have prolonged
lockdowns and delayed expectations of an economic rebound.

Click here http://tmsnrt.rs/2EmTD6j for an interactive chart
on the vaccine race.

The U.S. dollar retreated from its highest level since
mid-November against the Japanese yen as investors
rebalanced portfolios for month-end. The greenback slid 0.48%
against the yen and traded little changed against an index of
currencies, falling 0.002%.

Bitcoin jumped as much as 14% to a two-week high
after Tesla Inc chief Elon Musk tagged the
cryptocurrency in his Twitter biography.

French 10-year government bond yields, which
move inversely to price, rose four basis points after France's
gross domestic product contracted less than expected in the
fourth quarter of 2020.

U.S. Treasury yields rose, in line with those in Europe,
after data showed inflation perked up last month, while
employment costs rose, suggesting the world's largest economy is
on the mend from the devastating effects of the pandemic.

The U.S. yield curve steepened as long yields increased,
with the spread between 2-year and 10-year notes hitting 98.20
basis points, the widest in about a week.

The 10-year U.S. Treasury note rose 2.1 basis
points to yield 1.0757%.

Oil prices traded mixed as demand concerns caused by new
coronavirus variants and slow vaccine rollouts offset a cut in
Saudi Arabian oil supply and falling U.S. oil inventories.

Brent crude futures settled up 35 cents at $55.88 a
barrel. U.S. crude futures fell 14 cents to settle at
$52.20 a barrel.

Spot gold prices rose 0.16% to $1,843.31 an ounce.
U.S. gold futures settled up 0.5% to $1,850.30 an ounce.

(Additional reporting by Tom Westbrook in Singapore and Alwyn
Scott in New York; Editing by Will Dunham, Richard Pullin, Ana
Nicolaci da Costa, William Maclean, Larry King, Dan Grebler and
Richard Chang)

More News
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
13 Dec 2023 17:07

UK's FTSE 100 rises as pound slips on GDP data; awaits Fed rate decision

UK economy shrinks by 0.3% in October

*

Read more
12 Dec 2023 16:00

London close: Stocks slip as investors digest US inflation

(Sharecast News) - London's markets finished in the red on Tuesday, as investors digested a slight decrease in consumer inflation in the US, while the UK's unemployment figures remained stable.

Read more
12 Dec 2023 12:07

London midday: FTSE still firmer ahead of US inflation print

(Sharecast News) - London's markets remained relatively stable by midday on Tuesday, with the top-flight index still in the green after fresh jobs data showed a slowdown in wage growth.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:53

LONDON MARKET OPEN: FTSE 100 opens higher ahead of US CPI

(Alliance News) - Stock prices in London opened higher on Tuesday, as investors digest the latest UK unemployment data, before turning their eyes to US inflation this afternoon.

Read more
12 Dec 2023 08:37

AstraZeneca acquires vaccine developer Icosavax for USD1.1 billion

(Alliance News) - AstraZeneca PLC confirmed on Tuesday that it will buy Icosavax Inc, boosting its vaccine portfolio with an "innovative" treatment for respiratory viruses.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:16

AstraZeneca to buy US vaccine maker Icosavax for up to $1.1bn

(Sharecast News) - AstraZeneca said on Tuesday that it has agreed to buy Icosavax - a US-based clinical-stage biopharmaceutical company - for up to $1.1bn.

Read more
12 Dec 2023 02:00

UK companies pause China investment decisions as economy slows, survey shows

BEIJING, Dec 12 (Reuters) - A slowdown in both the Chinese and global economies is the biggest issue affecting British firms in the world's second-largest economy, beating geopolitical concerns and market access barriers, according to the British Chamber of Commerce in China.

Read more
11 Dec 2023 08:15

AstraZeneca says danicopan tests well as blood disorder treatment

(Alliance News) - AstraZeneca PLC on Monday reported "positive results" from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.